suMMARY Granulocyte-specific antinuclear antibodies (GS-ANA) were detected in the sera of 5 of 88 patients with ankylosing spondylitis (AS) (Wiik and Munthe, 1972) .
Antinuclear antibodies (ANA) generally do not show organ specificity and are detectable on a wide range of tissue substrates by the indirect immunofluorescent method. A notable exception is granulocyte-specific (GS) antibody, which reacts with nuclei of mature granulocytes (and monocytes) but not with nuclei of lymphocytes or cells of other tissues (Wiik and Munthe, 1972) .
GS-ANA occur uncommonly in health (Wiik, 1976) , and their highest incidence has been found in Felty's syndrome, rheumatoid arthritis, and systemic lupus erythematosus (Faber and Elling, 1966) . In a previous study we reported the presence of GS antibody in 20 % of cases ofjuvenile chronic arthritis (Rosenberg et al., 1975) . Although the presence of autoantibodies is not considered to be a feature of ankylosing spondylitis (Eghtedari et al., 1976) , Vasey and Kinsella (1977) detected leucocytereactive antinuclear antibodies in 60% of sera from 125 cases. In psoriatic arthritis (PsA) the incidence of organ-non-specific (ONS) ANA is low (Lambert et al., 1977 ), but we have noted the presence of granulocyte-specific antibody in some cases.
The aim of the present study was to determine the incidence of GS and ONS ANA in patients with AS, PsA, and psoriasis, and to determine whether the presence of ANA in these conditions was associated with other laboratory findings or with particular clinical features. (Moll and Wright, 1973) , and 25 cases of psoriasis not associated with arthritis. No patient was leucopenic (leucocytes <4 x 109/l). Ninty-one patients with malignant and nonmalignant diseases of the chest served as controls.
LEUCOCYTE PREPARATIONS
Ethanol-fixed cytocentrifuge preparations of human leucocytes from a healthy person were prepared as previously described (Rosenberg et al., 1975) . The blood group of the donor was shown to be unimportant (Rosenberg, unpublished The presence of soluble circulating immune complexes was detected using a 1251-Clq binding method (Zubler et al., 1976) .
Results
Granulocyte-specific ANA were detected in the serum from 5 patients with AS (6%) and 7 with PsA (13%) as shown in Table 1 Patients with AS and PsA who had either Gs-ANA or ONS ANA did not differ from those who were ANA negative with regard to sex, age of onset, duration of disease, peripheral joint involvement, uveitis, tissue type, treatment with drugs, or radiotherapy.
Discussion
The low incidence of granulocyte-specific ANA found in this study in ankylosing spondylitis does not accord with the report of Vasey and Kinsella (1977) , who found leucocyte-reactive ANA in 60% of 125 cases. These authors used unfixed, aged buffy coat leucocytes as substrate, but using a similar preparation we were unable to confirm their finding. Detection of GS-ANA requires nuclei to be damaged by repeated freezing and thawing as originally described by Elling (1967) or by treatment with alcohol (Wiik and Munthe, 1972) , and this might account for the low incidence of leucocyte-reactive ANA found by Vasey and Kinsella (1977) in their rheumatoid arthritis control group.
Eosinophil-specific ANA, which we have previously reported in some cases of juvenile chronic arthritis and adult RA (Rosenberg et al., 1975) , were not detected in the present study. This might be of diagnostic value.
Our finding of 25 U/ml ONS ANA in 17 % of AS cases is not in agreement with the reports of Eghtedari et al., (1976) and Vasey and Kinsella (1977) , who found a low incidence. This may reflect different levels of sensitivity in the detection systems employed and underlines the relevance of the international reference preparation to comparison of results of ANA tests obtained in different laboratories.
Although GS-ANA have been reported in healthy group.bmj.com on August 15, 2017 -Published by http://ard.bmj.com/ Downloaded from subjects with a similar frequency to ONS ANA (less than 10 %) by Wiik (1976) , we did not find GS-ANA in healthy controls or patients with non-rheumatic disease previously studied (Rosenberg et al., 1975) . Their occurrence in 13 % of cases of psoriatic arthritis in this study is therefore of interest. Such antibodies may have pathogenic significance in joint disease, since their presence in synovial fluid from rheumatoid joints has been reported by Elling et al. (1968) .
A significant level of ONS ANA (25 U/ml) was found in only 1 case of PsA, in agreement with the findings of Lambert et al. (1977) and in no case of psoriasis.
The pattern of nuclear staining obtained with many of the GS-ANA-positive sera was peripheral. This pattern with nuclei in tissue sections has been attributed to the presence in the serum of antibodies specific for DNA (Rothfield and Stollar, 1967 ), though we have not been able to show this association (Johnson and Holborow, unpublished) . Further, we did not find increased DNA-binding capacity in any of the sera that gave peripheral GS-ANA staining.
The absence of soluble immune complexes detectable by a Clq binding assay from all the groups studied conflicts with the finding of Braun-Falco et al. (1977) , who detected complexes by a similar technique in 70 % of cases of psoriasis and in 8 % of controls. Corrigall et al. (1978) , using an antibodymediated lymphocyte-induced cytotoxicity test, detected complexes in 61 % of 18 cases of ankylosing spondylitis. These discrepancies are unexplained. The presence of antinuclear antibodies in this study could not be shown to identify clinical subgroups within the diseases studied, and their significance in the individual patient remains unexplained. 
